Fundacio Privada Mon Clinic Barcelona

1 trials Academic / non-commercial

Filter these 1 trials by condition, phase, country and more.

Open in Search →

1 Registered trials

0 Recruiting

1 Completed trials

1 Countries active

18 Unique IMPs

100% Results reported

Phase IV

100%

1 of 1 completed trials have published summary results (EU CTR Article 37 — 12-month obligation).

View full Transparency Scoreboard →

Top indications

Chronic obstructive pulmonary disease 1

Top IMPs

ACLIDINIUM BROMIDE 1 FORMOTEROL FUMARATE 1 FORMOTEROL FUMARATE DIHYDRATE 1 FORMOTEROL FUMARATE DIHYDRATE, ACLIDINIUM BROMIDE 1 FORMOTEROL FUMARATE, ACLIDINIUM BROMIDE 1 GLYCOPYRRONIUM BROMIDE 1 GLYCOPYRRONIUM BROMIDE, INDACATEROL MALEATE 1 INDACATEROL 1 OLODATEROL 1 SALMETEROL 1 SALMETEROL XINAFOATE 1 TIOTROPIUM 1

All trials

1 total

THE ANTES B+ STUDY: AN OPEN-LABEL, PRAGMATIC, RANDOMIZED, CONTROLLED TRIAL OF TRIPLE THERAPY VERSUS LABA-LAMA COMBINATION TO IMPROVE CLINICA… Ended

2023-507304-32-00 Phase IV 1 country ACLIDINIUM BROMIDE; FORMOTEROL FUMARATE; FORMOTEROL FUMARATE DIHYDRATE; FORMOTER…

Showing 1–1 of 1 trials

← All sponsors A–Z